Sermorelin Results Timeline: What to Expect Month by Month

Sermorelin is a compounded growth-hormone-releasing hormone (GHRH) analog that prompts your own pituitary gland-not an external drug-to release more growth hormone. Most patients see the earliest lab changes within the first one to two months, but meaningful, doctor-confirmed increases in insulin-like growth factor-1 (IGF-1) typically show up by month three and continue through month six. Individual results depend on dose, adherence, age, sex, and baseline hormone status, so regular blood work is essential to track progress.

• Sermorelin binds to pituitary GHRH receptors and stimulates pulsatile growth hormone release, which the liver converts to IGF-1 for measurable effects (Vasylieva et al., 2026).
• In a retrospective review of hypogonadal men, mean IGF-1 rose from 159.5 ng/mL to 239.0 ng/mL after an average of 134 days of combined sermorelin and GHRP dosing (Sigalos et al., 2017).
• Modern anti-doping laboratories can detect sermorelin in urine at concentrations as low as 0.2 ng/mL using triple-quadrupole UHPLC-MS/MS methods (Cristea et al., 2023).
• Sermorelin is not FDA-approved; all commercially available products are patient-specific compounds prepared by 503A U.S. pharmacies (fda.gov).
• The most commonly reported side effects are temporary injection-site redness, flushing, or mild dizziness, and serious adverse events are rare according to a 2026 narrative safety review (Vasylieva et al., 2026).

Sermorelin is a short peptide that mimics natural GHRH

Sermorelin is a 29-amino-acid fragment of endogenous growth-hormone-releasing hormone that preserves the receptor-binding portion of the full 44-amino-acid sequence. It was originally marketed as the brand Geref for growth hormone testing but the manufacturer discontinued the product years ago. Today, sermorelin prescriptions are filled by 503A compounding pharmacies after a licensed provider determines individual need. Because it stimulates your own pituitary, it is considered a growth hormone secretagogue, not replacement therapy.

Unlike recombinant human growth hormone, sermorelin still relies on the body’s negative-feedback loops. That means surges are short-lived and physiologic, which lowers-but does not eliminate-the risk of excessive IGF-1 levels. If your prescriber issues sermorelin through sermorelin from Rx.com, you will receive detailed injection instructions and supplies shipped directly to your door.

Sermorelin triggers nightly growth hormone pulses

After subcutaneous injection, sermorelin reaches the pituitary in minutes, binds GHRH receptors, and initiates a growth hormone pulse that peaks about 20 minutes later (Vasylieva et al., 2026). The liver converts that burst into circulating IGF-1, which mediates most of the tissue-building and metabolic effects clinicians monitor.

Short half-life, big signal: Sermorelin’s plasma half-life is roughly 11 minutes, but the receptor activation it triggers can stimulate growth hormone release for up to two hours (Vasylieva et al., 2026). That short window is why providers often schedule injections 30-60 minutes before bedtime, aligning the drug-induced pulse with the body’s largest natural GH surge during slow-wave sleep.

For a deeper dive into how peptide prescriptions work under U.S. compounding laws, see our guide how online peptide prescriptions work.

Here is the realistic sermorelin results timeline

Most adults will not notice dramatic body composition changes immediately; the first “result” is a measurable rise in IGF-1 on lab work. The table below summarizes what doctors commonly look for at each checkpoint; exact timing can shift based on your dose, age, sex, sleep quality, and whether you pair sermorelin with a growth-hormone-releasing peptide.

Clinical evidence at month four: In the chart review of 14 compliant hypogonadal men, mean IGF-1 increased from 159.5 ng/mL to 239.0 ng/mL after about 134 days of nightly sermorelin plus GHRP injections-a statistically significant rise of nearly 80 ng/mL on average (Sigalos et al., 2017). While that study combined agents, it offers a conservative benchmark for what mid-term lab progress can look like under medical supervision.

Regular IGF-1 labs are the only reliable “before and after”

Unlike weight or mirror selfies, IGF-1 is an objective biomarker that rises in parallel with growth hormone activity. Clinicians usually draw IGF-1 every three months, but high-dose or combination protocols may warrant a six-week re-check. Always schedule labs at the same time of day and avoid injecting within 24 hours of the blood draw to limit acute fluctuations.

If you compete in regulated sports, disclose your therapy in advance. As the table shows, cutting-edge labs can spot tiny sermorelin levels days after your last dose.

Six factors that influence your sermorelin results

Response to peptide therapy is highly individual, but these variables consistently predict bigger or faster IGF-1 jumps.

Age and pituitary reserve: Adults under 40 may have a more robust pituitary response compared with individuals in their 60s.

Baseline IGF-1: The lower you start, the larger the potential rise, but also the harder it can be to reach mid-reference values safely.

Dose and injection timing: Nightly subcutaneous doses shortly before sleep mimic physiologic peaks more closely than morning injections.

Combination therapy: Adding a GHRP such as ipamorelin can produce a synergistic GH pulse, but also increases lab monitoring needs-see our ipamorelin dosage guide for details.

Sleep quality: Sermorelin amplifies natural nocturnal GH surges, so untreated sleep apnea or erratic bedtime schedules can blunt results.

Dietary protein and fasting glucose: High-protein diets support IGF-1 synthesis, whereas chronically elevated blood sugar can dampen the GH/IGF-1 axis.

How to maximize benefits and reduce risks

Consistency is king: Sermorelin must be taken every night; skipping doses can reset your progress.

Sterile technique: Wash hands, swab the vial top, and rotate injection sites to avoid local irritation.

Protein timing: A protein-rich snack earlier in the evening supports IGF-1 synthesis, but finish eating at least one hour before your shot to avoid insulin spikes.

Review other prescriptions: Glucocorticoids and uncontrolled hypothyroidism can blunt IGF-1 gains. Discuss all medications with your provider or see our virtual primary care guide for how to consolidate care online.

If your treatment plan includes oral medications like metformin or lisinopril, remember you can compare cash prices with a free Rx.com discount card at any time.